ARTICLE | Top Story
Novartis' NIBR taps Bradner to replace Fishman
September 25, 2015 12:10 AM UTC
Novartis AG (NYSE:NVS; SIX:NOVN) named James Bradner president of the Novartis Institutes for BioMedical Research (NIBR) and a member of Novartis' executive committee.
He replaces Mark Fishman, who will retire in March 2016 after 13 years with the company. ...